Literature DB >> 9321428

Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule.

Y van de Wal1, Y M Kooy, J W Drijfhout, R Amons, G K Papadopoulos, F Koning.   

Abstract

To understand the dominant association of celiac disease (CD) with the presence of HLA-DQ(alpha 1*0501, beta 1*0201), the peptide binding characteristics of this molecule were compared with that of the structurally similar, but non-CD-associated DQ(alpha 1*0201, beta 1*0202) molecule. First, naturally processed peptides were acid-extracted from immuno-affinity-purified DQ molecules of both types. Both molecules contained the Ii-derived CLIP sequence and a particular fragment of the major histocompatibility complex (MHC) class I alpha chain. Use of truncated analogues of these two peptides in cell-free peptide binding assays indicated that identical peptide frames are used for binding to the two DQ2 molecules. Detailed substitution analysis of the MHC class I peptide revealed identical side chain requirements for the anchor residues at p6 and p7. AT p1, p4, and p9, however, polar substitutions (such as N, Q, G, S, and T) were less well tolerated in the case of the DQ(alpha 1*0201, beta 1*0202) molecule. This most striking difference between the two DQ molecules is the presence of and additional anchor residue at p3 for the DQ(alpha 1*0201, beta 1*0202) molecule, whereas this residue was found not to be specifically involved in binding of peptides to DQ(alpha 1*0501, beta 1*0201). Similar results were obtained applying substitution analysis of the CLIP sequence. Molecular modelling of the DQ2 proteins complexed with the MHC class I and CLIP peptide corresponds well with the binding data. The results suggest that both CLIP and the MHC class I peptide bind DQ(alpha 1*0501, beta 1*0201) and DQ(alpha 1*0201, beta 1*0202) in a DR-like fashion, following highly similar binding criteria. This detailed characterization of unique peptide binding properties of the CD-associated DQ(alpha 1*0501, beta 1*0201) molecule should be helpful in the identification of CD-inducing epitopes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9321428     DOI: 10.1007/s002510050309

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  29 in total

Review 1.  Genetic factors underlying gluten-sensitive enteropathy.

Authors:  A S Peña; C Wijmenga
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

2.  The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.

Authors:  Willemijn Vader; Dariusz Stepniak; Yvonne Kooy; Luisa Mearin; Allan Thompson; Jon J van Rood; Liesbeth Spaenij; Frits Koning
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

3.  Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.

Authors:  Chu-Young Kim; Hanne Quarsten; Elin Bergseng; Chaitan Khosla; Ludvig M Sollid
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-12       Impact factor: 11.205

4.  Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire.

Authors:  Menno van Lummel; Peter A van Veelen; Arnaud Zaldumbide; Arnoud de Ru; George M C Janssen; Antonis K Moustakas; George K Papadopoulos; Jan W Drijfhout; Bart O Roep; Frits Koning
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

5.  Characterizing the binding motifs of 11 common human HLA-DP and HLA-DQ molecules using NNAlign.

Authors:  Massimo Andreatta; Morten Nielsen
Journal:  Immunology       Date:  2012-07       Impact factor: 7.397

6.  Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs.

Authors:  Gema Díaz; Benito Cañas; Jesús Vazquez; César Nombela; Javier Arroyo
Journal:  Immunogenetics       Date:  2004-11-24       Impact factor: 2.846

7.  T-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1.

Authors:  Dariusz Stepniak; L Willemijn Vader; Yvonne Kooy; Peter A van Veelen; Antonis Moustakas; Nikolaos A Papandreou; Elias Eliopoulos; Jan Wouter Drijfhout; George K Papadopoulos; Frits Koning
Journal:  Immunogenetics       Date:  2005-02-16       Impact factor: 2.846

Review 8.  Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease.

Authors:  P C Dubois; D A van Heel
Journal:  Clin Exp Immunol       Date:  2008-08       Impact factor: 4.330

9.  Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation.

Authors:  Lars-Egil Fallang; Elin Bergseng; Kinya Hotta; Axel Berg-Larsen; Chu-Young Kim; Ludvig M Sollid
Journal:  Nat Immunol       Date:  2009-08-30       Impact factor: 25.606

10.  Next-Generation HLA Sequence Analysis Uncovers Seven HLA-DQ Amino Acid Residues and Six Motifs Resistant to Childhood Type 1 Diabetes.

Authors:  Lue Ping Zhao; George K Papadopoulos; William W Kwok; Antonis K Moustakas; George P Bondinas; Annelie Carlsson; Helena Elding Larsson; Johnny Ludvigsson; Claude Marcus; Ulf Samuelsson; Ruihan Wang; Chul-Woo Pyo; Wyatt C Nelson; Daniel E Geraghty; Åke Lernmark
Journal:  Diabetes       Date:  2020-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.